A0A0M3M0G7 (A0A0M3M0G7_HUMAN) Homo sapiens (Human)

Programmed cell death 1 protein UniProtKBInterProInteractive Modelling

288 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q15116

Available Structures

34 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Complex structure of PD1 and 609A-Fab Heteromer
Q15116;
32-152
99.17THR;GOL;EDO;MG;PEG;CL;
PD-1 in complex with nivolumab Fab Heteromer
Q15116;
27-146
99.15
Complex structure of PD-1 and nivolumab-Fab Heteromer
Q15116;
25-142
100.0NAG;
Complex structure of toripalimab-Fab and PD-1 Heteromer
Q15116;
31-148
100.0NAG;NAG;
N-Glycosylation of PD-1 and glycosylation dependent binding of PD-1 specific monoclonal antibody ca… Heteromer
Q15116;
30-147
100.0NAG;NAG;NAG;
Crystal structure of human PD-L1 in complex with high affinity PD-1 mutant Heteromer
Q15116; Q9NZQ7;
29-146
90.52CL;
PD-1 in complex with Dostarlimab Heteromer
Q15116;
31-147
99.11
High-resolution structure of the cemiplimab Fab in complex with PD-1 Heteromer
Q15116;
31-147
99.08
High-affinity human PD-1 PD-L2 complex Heteromer
Q15116; Q9BQ51;
33-149
93.58MG;
Crystal structure of Fab of a PD-1 monoclonal antibody MW11-h317 in complex with PD-1 Heteromer
Q15116;
30-146
100NAG;NAG;
The complex structure of PD-1 and cemiplimab Heteromer
Q15116;
31-147
100.0
PD-1 extracellular domain in complex with Fab fragment from D12 antibody Heteromer
Q15116;
30-146
100.0NAG;NAG;
Study of the interactions of a novel monoclonal antibody, mAb059c, with the hPD-1 receptor Heteromer
Q15116;
33-148
99.14EDO;
Complex structure of GY-5 Fab and PD-1 Heteromer
Q15116;
32-147
100.0NAG;NAG;
Complex structure of GY-14 and PD-1 Heteromer
Q15116;
33-147
100.0
Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candid… Heteromer
Q15116;
32-146
100
High resolution structure of the human PD-1 in complex with pembrolizumab Fv Heteromer
Q15116;
32-146
99.13
hPD-1/NBO1a Fab complex Heteromer
Q15116;
33-147
98.85
PD1 signaling receptor bound to FAB Complex Heteromer
Q15116;
34-147
98.7
Structure of the complex of human programmed death-1 (PD-1) and its ligand PD-L1. Heteromer
Q15116; Q9NZQ7;
33-146
99.06NA;
Crystal structure of PD-1 in complex with a Fab Heteromer
Q15116;
31-144
99.06
Crystal structure of PD-1 in complex with a Fab Heteromer
Q15116;
30-143
99.06GOL;
Complex structure of PD-1 and tislelizumab Fab Heteromer
Q15116;
33-146
100NAG;
PD-1 in complex with pembrolizumab Fab Heteromer
Q15116;
31-143
99.11
Structure of Sasanlimab Fab in complex with PD-1 Heteromer
Q15116;
32-144
100GOL;
Human PD-1 ectodomain complexed with Pembrolizumab Fab Heteromer
Q15116;
34-146
98.97
Crystal structure of PD-1 in complex with tislelizumab Fab Heteromer
Q15116;
33-145
100.0
C-SH2 domain of SHP-2 in complex with phospho-ITSM of PD-1 Heteromer
Q06124; Q15116;
244-254
100
Structure of the N-SH2 domain of the human tyrosine-protein phosphatase non-receptor type 11 in com… Heteromer
Q06124; Q15116;
245-254
100
Structure of the N-SH2 domain of the human tyrosine-protein phosphatase non-receptor type 11 in com… Heteromer
Q06124; Q15116;
221-229
100
Crystal structure of the extracellular domain of human PD-1monomer33-149
99.07
Human programmed cell death 1 receptormonomer34-150
99.14
Human apo PD-1 triple mutantmonomer33-147
97.3CL;
Human apo PD-1 double mutantmonomer33-147
97.39CL;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6jjp.2.Cmonomer0.7729-146
100.00